Clinical trials: Xenotransplantation

Heart Transplantation

SCHEDULE Follow Up Visit 5-7 yr

• Completed
• Age: All ages
• Phase 4
• Results posted

The major aim of this extension study was to evaluate the long-term effect (i.e. 5 to 7 years) of early initiation of everolimus and early elimination of CsA compared to standard immunosuppressive regimen including CsA on primary…

Trial name

CRAD001ANO05 (NCT02864706)

Testing

Everolimus, Cyclosporine, Mycophenolate mofetil

Where

6 sites in Denmark, Norway and 1 more

Volunteers

95 people

Sponsor

Novartis Pharmaceuticals